Altaroc
Newsroom
etc.
Company

Vivacy joins forces with Shanghai Pharmaceuticals for a new breakthrough in the Chinese aesthetics market

Published on
13/11/2024
Amended on
13/11/2024
0
minute(s)
Founded in 2007 by French entrepreneur Waldemar Kita, Vivacy has established itself as a world leader in dermal fillers, with injectable products based on hyaluronic acid, a component naturally present in the human body. Vivacy stands out for its patented Class III medical devices, which combine ease of injection and high quality, bringing safety and satisfaction to patients. With a patient retention rate of over 90%, Vivacy also offers specialized training courses for healthcare professionals.
By
Charles Pinsolle
Charles Pinsolle
This article has been automatically translated. Please excuse any inaccuracies or translation errors.

To strengthen its international development, Vivacy, a company featured in Vintage Altaroc Odyssey 2022, has signed a strategic distribution agreement with Shanghai Pharmaceuticals, China's largest importer of medicines and a leading player in the pharmaceutical sector. This strategic partnership with the Chinese market comes at a time when Vivacy is continuing to expand in a sector driven by growing global demand.

An alliance to consolidate Vivacy's presence in Asia

Thanks to this partnership with Shanghai Pharmaceuticals, Vivacy is closer to Chinese professionals and consumers to meet the growing demand for quality medical aesthetic solutions. This collaboration enables Vivacy to extend its expertise and quality standards beyond its traditional markets, as the appeal of aesthetic care continues to grow in Asia.

With a solid reputation built on high-quality products and a patient-oriented approach, Vivacy sees this expansion as an opportunity to play an active part in China's aesthetic revolution. Shanghai Pharmaceuticals, already well established in this market, will facilitate the introduction of Vivacy's hyaluronic acid range, guaranteeing robust local support and optimal access to products.

No items found.

The latest Hors-Séries

Special report N°7 - Nordic Capital

13
item(s)

Special report N°8 - Hg

14
item(s)

Special Summer 2024 feature

16
item(s)
Newsletter
Subscribe to our newsletter to keep up to date with all the latest news.
No items found.
Europe
Rest of world
Healthcare